Page last updated: 2024-08-24

imiquimod and Erythema

imiquimod has been researched along with Erythema in 22 studies

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (4.55)18.2507
2000's14 (63.64)29.6817
2010's5 (22.73)24.3611
2020's2 (9.09)2.80

Authors

AuthorsStudies
Bhuvarahamurthy, S; Kalaiyazhagan, A; Meganathan, J; Ramamoorthy, R; Venugopal, B; Vijayapoopathi, S1
Funasaka, Y; Kawana, S; Oyama, S; Saeki, H; Tsuchiya, SI1
Di, TT; Li, P; Lin, Y; Meng, YJ; Wang, MX; Wang, N; Wang, Y; Xie, XJ; Xu, XL; Zhang, L; Zhao, JX1
Landucci, G; Savoia, P; Tarantino, V; Veronese, F; Zavattaro, E1
Wang, L; Zeng, Y; Zheng, YQ1
Schmutz, JL1
Adams, S; Angiulli, A; Angiulli, F; Berman, RS; Berner, N; Bhardwaj, N; Chiriboga, L; Cruz, CM; Gnjatic, S; Hardin, E; Hoffman, EW; Holman, RM; Jungbluth, A; Manches, O; Nonaka, D; O'Neill, DW; Old, L; Pan, L; Pavlick, AC; Ritter, E; Shao, Y; Shapiro, RL; Siu, K; Venhaus, RR1
Cannon, PS; Huilgol, SC; O'Donnell, B; Selva, D1
Bayerl, C; Feller, G; Goerdt, S1
Cornelison, RL; Crowson, N; Garcia, C; Haque, R; Jankey, C; Kuwahara, R; Mackinnis, C; Naylor, MF; Odom, C; Teague, K1
Micali, G; Nasca, MR; Tedeschi, A1
Barnetson, RS; Halliday, GM; Lee, JH; McKane, S; Ooi, T; Slade, HB; Zhuang, L1
Tanghetti, E; Werschler, P1
Blasco Melguizo, J; Bukhardt Pérez, MP; Naranjo Díaz, MJ; Naranjo Sintes, R; Ruiz-Villaverde, R1
Colaco, SM; Heaphy, MR; Palmer, G; Ricotti, CA; Shamma, HN; Trevino, J1
Bernardino, CR; Murchison, AP; Soloman, AR; Washington, CV1
Fargnoli, MC; Micantonio, T; Peris, K; Piccolo, D1
Baker, D; Edwards, L; Eron, L; Ferenczy, A; Fox, TL; Hougham, AJ; Owens, ML; Schmitt, KA1
Barasso, R; Carey-Yard, M; Eul, A; Gollnick, H; Jappe, U; Milde, K; Ward, K1
Brown, DR; Douglas, JM; Ferenczy, A; Fife, KH; Owens, ML; Smith, M1
Barba, AR; Berman, B; Kapoor, S1
Flowers, F1

Trials

9 trial(s) available for imiquimod and Erythema

ArticleYear
Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant.
    Journal of immunology (Baltimore, Md. : 1950), 2008, Jul-01, Volume: 181, Issue:1

    Topics: Adjuvants, Immunologic; Adult; Aged; Aminoquinolines; Antibody Formation; Antigens, Neoplasm; Biopsy; Cancer Vaccines; Epitope Mapping; Erythema; Female; Humans; Imiquimod; Immunization; Male; Melanoma; Membrane Proteins; Middle Aged; Pilot Projects; Toll-Like Receptor 7

2008
Treatment of lentigo maligna with topical imiquimod.
    The British journal of dermatology, 2003, Volume: 149 Suppl 66

    Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Cytokines; Drug Administration Schedule; Erythema; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Ointments; Skin Ulcer; Treatment Outcome

2003
Imiquimod-induced regression of actinic keratosis is associated with infiltration by T lymphocytes and dendritic cells: a randomized controlled trial.
    The British journal of dermatology, 2006, Volume: 154, Issue:1

    Topics: Aged; Aminoquinolines; Biomarkers; Cell Movement; Dendritic Cells; Double-Blind Method; Drug Eruptions; Erythema; Female; Humans; Imiquimod; Immunophenotyping; Interferon Inducers; Keratosis; Male; Middle Aged; Photosensitivity Disorders; Skin; T-Lymphocyte Subsets; Treatment Outcome

2006
Comparison of 5% 5-fluorouracil cream and 5% imiquimod cream in the management of actinic keratoses on the face and scalp.
    Journal of drugs in dermatology : JDD, 2007, Volume: 6, Issue:2

    Topics: Administration, Topical; Adult; Aminoquinolines; Disease Management; Erythema; Facial Dermatoses; Fluorouracil; Humans; Imiquimod; Keratosis; Scalp Dermatoses; Treatment Outcome

2007
Laser-assisted tattoo removal with topical 5% imiquimod cream.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2007, Volume: 33, Issue:9

    Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Combined Modality Therapy; Double-Blind Method; Erythema; Humans; Imiquimod; Laser Therapy; Prospective Studies; Pruritus; Tattooing

2007
Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
    Archives of dermatology, 1998, Volume: 134, Issue:1

    Topics: Adjuvants, Immunologic; Administration, Cutaneous; Adult; Aminoquinolines; Anus Diseases; Condylomata Acuminata; Dermatitis; Double-Blind Method; Drug Administration Schedule; Erythema; Female; Follow-Up Studies; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Incidence; Interferon Inducers; Male; Ointments; Pharmaceutical Vehicles; Placebos; Recurrence; Remission Induction; Safety; Self Administration; Treatment Outcome

1998
Safety and efficacy of imiquimod 5% cream in the treatment of penile genital warts in uncircumcised men when applied three times weekly or once per day.
    International journal of STD & AIDS, 2001, Volume: 12, Issue:1

    Topics: Administration, Topical; Adolescent; Adult; Aminoquinolines; Condylomata Acuminata; Erythema; France; Germany; Humans; Imiquimod; Interferon Inducers; Male; Pain; Penile Diseases; Pruritus

2001
Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day.
    Sexually transmitted diseases, 2001, Volume: 28, Issue:4

    Topics: Adult; Aged; Aminoquinolines; Antibodies, Viral; Condylomata Acuminata; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythema; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged; Neopterin; Papillomaviridae; Ulcer

2001
An open label safety study of topical imiquimod 5% cream in the treatment of Molluscum contagiosum in children.
    Dermatology online journal, 2001, Volume: 7, Issue:1

    Topics: Administration, Topical; Adolescent; Aminoquinolines; Child; Child, Preschool; Erythema; Humans; Imiquimod; Infant; Interferon Inducers; Molluscum Contagiosum; Pruritus

2001

Other Studies

13 other study(ies) available for imiquimod and Erythema

ArticleYear
Nutraceutical combination ameliorates imiquimod-induced psoriasis in mice.
    Chemical biology & drug design, 2023, Volume: 102, Issue:6

    Topics: Animals; Cannabidiol; Dietary Supplements; Disease Models, Animal; Erythema; Humans; Imiquimod; Inositol; Mice; Mice, Inbred BALB C; Psoriasis; Skin

2023
Increased number of mast cells in the dermis in actinic keratosis lesions effectively treated with imiquimod.
    The Journal of dermatology, 2017, Volume: 44, Issue:8

    Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Cell Count; Dermis; Dermoscopy; Erythema; Female; Humans; Imiquimod; Immunohistochemistry; Keratosis, Actinic; Ki-67 Antigen; Male; Mast Cells; Proto-Oncogene Proteins c-kit; Toll-Like Receptor 7; Treatment Outcome

2017
Acetyl-11-keto-β-boswellic acid inhibits the secretion of cytokines by dendritic cells via the TLR7/8 pathway in an imiquimod-induced psoriasis mouse model and in vitro.
    Life sciences, 2018, Aug-15, Volume: 207

    Topics: Aminoquinolines; Animals; CD4-Positive T-Lymphocytes; Cell Differentiation; Cell Proliferation; Coculture Techniques; Cytokines; Dendritic Cells; Erythema; Imiquimod; Inflammation; Interleukin-12 Subunit p35; Interleukin-23 Subunit p19; Male; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Psoriasis; RNA, Messenger; Signal Transduction; Spleen; Toll-Like Receptor 7; Toll-Like Receptor 8; Triterpenes

2018
Efficacy of topical imiquimod 3.75% in the treatment of actinic keratosis of the scalp in immunosuppressed patients: our case series.
    The Journal of dermatological treatment, 2020, Volume: 31, Issue:3

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Erythema; Female; Humans; Imiquimod; Immunocompromised Host; Keratosis, Actinic; Male; Middle Aged; Scalp; Treatment Outcome

2020
Vagarious successful treatment of recalcitrant warts in combination with CO2 laser and imiquimod 5% cream.
    Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology, 2014, Volume: 16, Issue:6

    Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Child; Combined Modality Therapy; Erythema; Female; Humans; Imiquimod; Lasers, Gas; Warts

2014
[Adverse effects of Aldara(®): polymorphous erythema and chronic ulceration].
    Annales de dermatologie et de venereologie, 2015, Volume: 142, Issue:1

    Topics: Aminoquinolines; Antineoplastic Agents; Erythema; Humans; Imiquimod; Skin Ulcer

2015
The ophthalmic side-effects of imiquimod therapy in the management of periocular skin lesions.
    The British journal of ophthalmology, 2011, Volume: 95, Issue:12

    Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma, Basal Cell; Conjunctivitis; Erythema; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Retrospective Studies; Skin Neoplasms; Treatment Outcome

2011
Experience in treating molluscum contagiosum in children with imiquimod 5% cream.
    The British journal of dermatology, 2003, Volume: 149 Suppl 66

    Topics: Adjuvants, Immunologic; Aminoquinolines; Child; Child, Preschool; Drug Administration Schedule; Erythema; Female; Follow-Up Studies; Humans; Imiquimod; Male; Molluscum Contagiosum; Ointments; Pain; Pruritus

2003
Topical treatment of intraepithelial penile carcinoma with imiquimod.
    Clinical and experimental dermatology, 2003, Volume: 28 Suppl 1

    Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Erythema; Humans; Imiquimod; Male; Middle Aged; Pain; Penile Neoplasms; Treatment Outcome

2003
Basal cell carcinoma: treatment with imiquimod.
    International journal of dermatology, 2007, Volume: 46, Issue:5

    Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Aminoquinolines; Biopsy; Carcinoma, Basal Cell; Erythema; Female; Humans; Imiquimod; Male; Middle Aged; Skin; Skin Neoplasms; Spain; Time Factors; Treatment Outcome

2007
Ocular effects of imiquimod with treatment of eyelid melanoma in situ.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2007, Volume: 33, Issue:9

    Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Conjunctiva; Erythema; Eyelid Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Skin; Skin Neoplasms; Visual Acuity

2007
Letter: Changes in dermoscopic features in superficial basal cell carcinomas treated with imiquimod.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2007, Volume: 33, Issue:11

    Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Dermoscopy; Drug Monitoring; Erythema; Female; Humans; Imiquimod; Immunologic Factors; Male; Middle Aged; Remission Induction; Skin Neoplasms; Skin Ulcer

2007
Imiquimod in the treatment of actinic keratoses and other intraepithelial neoplasms.
    International journal of dermatology, 2002, Volume: 41 Suppl 1

    Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Bowen's Disease; Cicatrix; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythema; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Keratosis; Paget Disease, Extramammary; Photochemotherapy; Pruritus; Randomized Controlled Trials as Topic; Skin Neoplasms

2002